Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

After a decade of relying on blood transfusions for her congenital disorder, 11-year-old Dang Thanh Mai Thu is now recovering from a life-saving bone marrow transplant.

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

It means that eligible SCD patients in England now have access to the therapy following the prior agreement for transfusion-dependent beta thalassemia (TDT) patients announced last August. “Today is ...

This causes BCL11A to not be made which in turn allows gamma globin ... notably sickle cell disease and beta thalassemia. “Importantly it is also likely that making gamma globin is safe – it is our ...

It means that eligible SCD patients in England now have access to the therapy following the prior agreement for transfusion-dependent beta thalassemia (TDT) patients announced last August.

Two mechanisms are responsible for iron overload in β-thalassemia: increased iron absorption due to ineffective erythropoiesis and blood transfusions. This review examines the mechanisms of myocardial ...

Jan 22 (Reuters) - Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States ...

Ahead of the stable launch in March, Google is rolling out Android 15 QPR2 Beta 3 for Pixel devices. Quarterly Platform Releases deliver more significant changes compared to monthly bug fixes.

Generation Beta, or Gen Beta, the firm said in a research report, is represented by those born between 2025 and 2039. Their parents will be younger millennials and older Gen Zs, and many will live ...